SYK
Stryker Corporation · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website ryker.com
- Employees(FY) 51000
- ISIN US8636671013
Performance
-2.08%
1W
+11.39%
1M
-0.95%
3M
-2.59%
6M
+5.3%
YTD
+13.81%
1Y
Profile
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Technical Analysis of SYK 2025-05-22
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2025-05-20 10:26
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System(Zacks Investment Research)
- 2025-05-19 13:01
- 2025-03-26 22:15
- 2025-03-26 08:29
- 2025-03-26 04:15
Stryker announces Annual Meeting of Shareholders(Globenewswire)
- 2025-03-22 00:31
- 2025-03-20 21:40
- 2025-03-20 21:05
Invesco Health Care Fund Q4 2024 Commentary(Seekingalpha)
- 2025-03-20 20:23
- 2025-03-18 23:03
- 2025-03-17 19:01
4 takeaways from AAOS 2025(Yahoo Finance)
- 2025-03-12 21:00
1 Large-Cap Stock with Solid Fundamentals and 2 to Avoid(Yahoo Finance)
- 2025-03-11 03:59
Analyst Report: Stryker Corporation(Yahoo Finance)
- 2025-03-11 00:08
- 2025-03-10 20:03
- 2025-03-07 00:36
- 2025-03-05 20:45
- 2025-03-04 19:07
- 2025-03-03 19:07
Stryker launches Sync Badge(Prnewswire)
- 2025-03-01 05:14
3 Growth Stocks to Buy and Hold Forever(Yahoo Finance)
- 2025-02-27 15:04
- 2025-02-26 22:18
- 2025-02-24 17:38
- 2025-02-23 16:23
- 2025-02-19 19:30
- 2025-02-19 15:49
Stryker concludes Inari Medical acquisition for $4.9bn(Yahoo Finance)
- 2025-02-17 11:21
Stryker announces launch of ProCeed hospital bed to enhance care(Hospital Management)
- 2025-02-17 07:29
- 2025-02-16 19:07
Stryker launches ProCeed hospital bed(PR Newswire)
- 2025-02-16 14:07
Stryker launches ProCeed hospital bed(Prnewswire)
Page 1 of 5
previousnext
Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.